ANA
LLUCH HERNANDEZ
EMÈRIT/A UNIVERSITAT
Moscow City Oncology Hospital №62
Moscú, RusiaPublications in collaboration with researchers from Moscow City Oncology Hospital №62 (1)
2010
-
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
The Lancet, Vol. 375, Núm. 9712, pp. 377-384